Captopril in the Treatment of Hypertension in Type I and Type II Diabetic Patients

Overview

Journal J Hypertens Suppl

Date 1985 Nov 1

PMID 3910773

Citations 7

Authors

G Gambaro

F Morbiato

E Cicerello

M Del Turco

L Sartori

A DAngelo

G Crepaldi

Affiliations

Soon will be listed here.

Abstract

Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.

Citing Articles

Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Baba T, Ishizaki T Drugs. 2017; 43(4):464-489.

PMID: 28421556 DOI: 10.2165/00003495-199243040-00004.

Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Baba T, Neugebauer S, Watanabe T Drugs. 1997; 54(2):197-234.

PMID: 9257079 DOI: 10.2165/00003495-199754020-00002.

Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension.

Baba T, Kodama T, Ishizaki T Eur J Clin Pharmacol. 1993; 45(1):23-7.

PMID: 8405025 DOI: 10.1007/BF00315345.

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Brogden R, Todd P, Sorkin E Drugs. 1988; 36(5):540-600.

PMID: 3063499 DOI: 10.2165/00003495-198836050-00003.

ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?.

Kelleher C Drugs. 1990; 39(5):639-45.

PMID: 2191846 DOI: 10.2165/00003495-199039050-00001.